MetaADEDB 2.0 @ LMMD
Hypersplenism
(UMLS:C0020532)
Definition:
Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.
UMLS ID:
C0020532
MeSH ID:
D006971
Classification:
Name:
Hemic and Lymphatic Diseases
MeSH Tree Number(s):
C15.604.744.293
Synonym(s)
1.
Hypersplenism
2.
Big spleen syndrome
3.
HYPERSPLENISM
4.
Hypersplenia
5.
Hypersplenism syndrome
6.
Hypersplenism, NOS
7.
hyperfunction; spleen
8.
hypersplenism
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1ClozapineFAERS: 16OFFSIDES
US FAERS
2DeferasiroxFAERS: 7OFFSIDES
US FAERS
3EpoprostenolFAERS: 6US FAERS
4HydromorphoneFAERS: 4US FAERS
5IsotretinoinFAERS: 3US FAERS
6Ruxolitinib phosphateFAERS: 3US FAERS
74-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 2US FAERS
8AlendronateFAERS: 2US FAERS
9BosentanFAERS: 2US FAERS
10SorafenibFAERS: 2US FAERS
11TacrolimusFAERS: 2US FAERS
12AripiprazoleFAERS: 1US FAERS
13CarbamazepineFAERS: 1US FAERS
14CiprofloxacinFAERS: 1OFFSIDES
US FAERS
15CysteamineFAERS: 1US FAERS
16DeferiproneFAERS: 1SIDER
US FAERS
17DexamethasoneFAERS: 1US FAERS
18DidanosineFAERS: 1US FAERS
19DipyridamoleFAERS: 1US FAERS
20EpoprostenolFAERS: 1SIDER
US FAERS
21Fingolimod HydrochlorideFAERS: 1US FAERS
22Imatinib MesylateFAERS: 1US FAERS
23LamivudineFAERS: 1US FAERS
24LenalidomideFAERS: 1OFFSIDES
US FAERS
25RivastigmineFAERS: 1US FAERS
26TadalafilFAERS: 1US FAERS
27TelbivudineFAERS: 1US FAERS
28ThalidomideFAERS: 1US FAERS
29Viekira PakFAERS: 1US FAERS
30apixabanFAERS: 1US FAERS
31carbidopa, levodopa drug combinationFAERS: 1US FAERS
32lanreotideFAERS: 1US FAERS
33tofacitinibFAERS: 1US FAERS
34BortezomibOFFSIDES
35BromocriptineOFFSIDES
36DacarbazineOFFSIDES
37ErythromycinOFFSIDES
38HydroxyureaSIDER
39Isoniazid448941CTD
40LactuloseOFFSIDES
41LevetiracetamOFFSIDES
42MethylprednisoloneOFFSIDES
43NelfinavirOFFSIDES
44OxacillinOFFSIDES
45TimololOFFSIDES
46TobramycinOFFSIDES
47TretinoinOFFSIDES
Similar ADE(s)
NameSemantic Similarity
1Splenic Infarction31.8%
2Splenic Neoplasms31.8%
3Adenitis31%
4Histiocytosis31%
5Lymphadenitis31%
6Lymphangitis31%
7Lymphedema31%
8Thymus Hyperplasia31%
9Pseudolymphoma31%
10Lymphadenopathy31%
11Splenic Rupture24.1%
12Lymphocele20.9%
13Lymphoproliferative Disorders20.9%
14Lymphatic Abnormalities20.9%
15Thymus Neoplasms20.5%
16Elephantiasis20%
17Lymphangiectasis, Intestinal20%
18Sarcoidosis20%
19Elephantiasis Nostras Verrucosa20%
20Splenosis17.4%
21Mucocutaneous Lymph Node Syndrome15.3%
22Lymphohistiocytosis, Hemophagocytic14.8%
23Erdheim-Chester Disease14.8%
24Granuloma13.6%
25Histiocytic Disorders, Malignant13.6%
26Agammaglobulinemia13.6%
27Histiocytosis, Langerhans-Cell13.3%
28Tumor Lysis Syndrome13.3%
29Heavy Chain Disease12.4%
30Infectious Mononucleosis10.6%
31Anemia10.3%
32Blood Coagulation Disorders10.3%
33Blood Platelet Disorders10.3%
34Bone Marrow Diseases10.3%
35Hemorrhagic Disorders10.3%
36Leukocyte Disorders10.3%
37Methemoglobinemia10.3%
38Pancytopenia10.3%
39Polycythemia10.3%
40Sulfhemoglobinemia10.3%
41Thrombophilia10.3%
42Erythrocytosis10.3%
43Lymphoma10.2%
44Disseminated Intravascular Coagulation10%
45Protein S Deficiency10%
46Thymoma9.9%
47Sezary Syndrome9.9%
48Malignant histiocytosis9.9%
49Sarcoidosis, Pulmonary9.9%
50Histiocytic sarcoma9.9%
51Thrombocythemia, Essential8.9%
52Waldenstrom Macroglobulinemia8.5%
53Autoimmune Lymphoproliferative Syndrome8.2%
54Thrombocytosis7.7%
55Hodgkin Disease7.4%
56Lymphoma, Non-Hodgkin7.4%
57Leukemia, T-Cell7.3%
58Transfusion Reaction7.3%
59Leukemia, B-Cell7.3%
60Hypotensive Transfusion Reaction7.3%
61Thrombasthenia7.3%
62Antithrombin III Deficiency7.3%
63Protein C Deficiency7.3%
64Pregnancy Complications, Hematologic7%
65Hematologic Neoplasms7%
66Anemia, Hemolytic6.7%
67Anemia, Macrocytic6.7%
68Eosinophilia6.7%
69Hypoproteinemia6.7%
70Leukopenia6.7%
71Thrombocytopenia6.7%
72Leukostasis6.7%
73Bone Marrow Neoplasms6.7%
74MYELODYSPLASTIC SYNDROME6.7%
75Eosinophilic Granuloma6.6%
76Vitamin K Deficiency6.6%
77Afibrinogenemia6.6%
78Factor VII Deficiency6.6%
79Factor X Deficiency6.6%
80Factor XII Deficiency6.6%
81Hemophilia A6.6%
82Activated Protein C Resistance6.6%
83Factor II deficiency6.6%
84Factor VIII Deficiency6.6%
85Factor V deficiency6.6%
86Factor XI Deficiency6.6%
87Hypoprothrombinemias6.6%
88Hemoglobinuria, Paroxysmal6.5%
89Leukemoid Reaction6.5%
90Lymphoma, Follicular6%
91T-Cell Lymphoma6%
92Mantle cell lymphoma6%
93Precursor B-Cell Lymphoblastic Leukemia-Lymphoma6%
94Leukemia, Large Granular Lymphocytic6%
95Precursor T-Cell Lymphoblastic Leukemia-Lymphoma6%
96Composite Lymphoma5.9%
97Polycythemia Vera5.8%
98Lymphangioleiomyomatosis5.8%
99Lymphoma, T-Cell, Cutaneous5.4%
100Lymphoma, AIDS-Related5.4%
101Enteropathy-Associated T-Cell Lymphoma5.4%
102Primary Effusion Lymphoma5.4%
103Anemia, Diamond-Blackfan5.2%
104Mycosis Fungoides5.1%
105Lymphomatoid Papulosis5.1%
106Plasmablastic lymphoma5.1%
107Primary Myelofibrosis4.9%
108Agranulocytosis4.9%
109Anemia, Megaloblastic4.9%
110Lymphocytosis4.9%
111Myelofibrosis4.9%
112Myeloid Metaplasia4.9%
113Hypoalbuminemia4.9%
114Hypereosinophilic syndrome4.9%
115bone marrow fibrosis4.9%
116Thrombotic Microangiopathies4.9%
117Purpura, Thrombotic Thrombocytopenic4.7%
118Anemia, Neonatal4.5%
119Leukocytosis4.5%
120Paraproteinemias4.5%
121Pelger-Huet Anomaly4.5%
122Pleocytosis4.5%
123Wiskott-Aldrich Syndrome4.5%
124Lymphomatoid Granulomatosis4.4%
125Anemia, Sickle Cell4.3%
126Thalassemia4.3%
127Neutropenia4.1%
128Cryoglobulinemia3.9%
129Monoclonal Gammopathy of Undetermined Significance3.9%
130Febrile Neutropenia3.6%
131Burkitt Lymphoma3.6%
132Autoimmune thrombocytopenia3.6%
133Immune thrombocytopenic purpura3.6%
134Hemolytic-Uremic Syndrome3.5%
135Hypergammaglobulinemia3.4%
136Sickle Cell Trait3.4%
137Lymphopenia3.4%
138Transfusion-Related Acute Lung Injury3.4%
139Ecchymosis3.3%
140Petechiae3.3%
141Purpura3.3%
142Job Syndrome3.3%
143Fanconi Anemia3.3%
144Leukemia, Myelomonocytic, Chronic3.3%
145Purpura, Hyperglobulinemic3.3%
146Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative3.3%
147Thrombocytopenic purpura3.1%
148Atypical Hemolytic Uremic Syndrome3%
149Multiple Myeloma2.8%
150Pulmonary Eosinophilia2.8%
151Eosinophilic Pneumonia2.8%
152Leukemia, Myeloid, Chronic-Phase2.7%
153Hydrops Fetalis2.7%
154Anemia, Pernicious2.7%
155Eosinophilia-Myalgia Syndrome2.5%
156Acute Chest Syndrome2.5%
157Chronic granulomatous disease2.5%
158Shwartzman Phenomenon2.5%
159Hemangioma, Cavernous2.5%
160Scurvy2.4%
161Purpura Fulminans2.4%
162Waterhouse-Friderichsen Syndrome2.3%
163Niemann-Pick Disease, Type C2.2%
164POEMS Syndrome2%
165Kernicterus1.9%
166Pseudoxanthoma Elasticum1.3%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.